
Conflicting views in experimental carcinogenesis: a commentary on design and methodological deficiencies in the follow-up validation studies on radiofrequency radiation
Conflicting views in experimental carcinogenesis often arise due to differences in study design among reported studies. For carcinogenicity assessments, regulatory agencies, such as the US Food and Drug Administration (FDA), and intergovern
